ACADIA Pharmaceuticals Inc. (ACAD) announced after the bell Tuesday that it intends to offer and sell shares of its common stock in an underwritten public offering. The stock is now down 0.62 on 46K shares.
ACADIA Pharmaceuticals traded in a range throughout Tuesday's session and closed up by 0.25 at $12.95. The stock finished near the middle of a 1-month range at the highs of the year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.